Brazil’s federal prosecutors sue for strict e-cigarette rules, urging regulation over a “paper ban”

Jan.30
Brazil’s federal prosecutors sue for strict e-cigarette rules, urging regulation over a “paper ban”
Brazil’s Federal Public Prosecutor’s Office (MPF) has filed a public civil action seeking to compel the federal government and Anvisa to establish a strict, enforceable regulatory framework for electronic smoking devices, replacing the current blanket ban. The lawsuit calls for mandatory product registration, nicotine caps, bans on youth-targeted advertising, and clear health warnings on packaging, and demands a national consumption report and an implementation timetable within 90 days.

Key points

 

  • Brazil’s Federal Public Prosecutor’s Office (MPF) filed a public civil action seeking to compel the federal government and Anvisa to create an enforceable control-and-oversight model for electronic smoking devices (DEFs).
  • The lawsuit argues the current total prohibition has failed to stop use and has pushed the market underground, boosting smuggling and illegal sales.
  • Requested measures include mandatory product registration, maximum nicotine limits, strict youth-protection marketing bans, and clear health warnings on packaging.
  • MPF asks for a detailed national consumption report and a timetable to implement new rules within 90 days.
  • MPF also seeks R$1 billion in collective moral damages for regulatory omission.

 


 

According to information released by Brazil’s Federal Public Prosecutor’s Office (MPF), prosecutors have filed a public civil action seeking to force the federal government and the National Health Surveillance Agency (Anvisa) to establish a robust regulatory and enforcement framework for electronic smoking devices (DEFs), commonly referred to as e-cigarettes or vaporizers. 

 

The goal is to replace Brazil’s current total ban with stringent, cigarette-like rules that allow authorities to supervise manufacturing, sales, and marketing.

 

The action was brought by federal prosecutors Cléber Eustáquio Neves and Onésio Soares Amaral, who argue that the absence of a workable regulatory regime prevents sanitary control, facilitates youth access to devices containing unknown substances, and adds pressure to public healthcare spending.

 

MPF is asking the court to require rules that include mandatory product registration, maximum nicotine limits, a total prohibition of marketing aimed at children and adolescents, and clear health warnings on packaging. Prosecutors also want the federal government and Anvisa to submit—within 90 days—a detailed report on consumption in Brazil and a timeline for implementing the new regulatory model.

 

The lawsuit contends that despite the formal prohibition, vaping products remain widely available in Brazil’s clandestine market across multiple formats, flavors, and device types, sold openly through social networks, messaging apps, and leisure venues. MPF says enforcement struggles to keep pace with the market’s speed, leaving the state unable to protect vulnerable groups such as adolescents.

 

On health risks, MPF points to technical analyses indicating that illicit devices may contain high nicotine concentrations, heavy metals (including lead, nickel, and chromium), and chemical solvents or additives without safety assessment. Prosecutors also argue that a “ban on paper” can create a false sense of security, noting that many users may be unaware nicotine is present in the products they use.

 

The filing links vaping to serious pulmonary conditions—such as bronchitis, COPD, “popcorn lung,” and vaping-associated lung injury (EVALI)—as well as cardiovascular harms and early nicotine dependence.

 

MPF further argues that the illegal market profits from sales while Brazil’s public health system (SUS) pays for treatment. With regulation, the state could levy specific taxes to support healthcare costs, require corporate accountability for harms, and improve monitoring of public expenditures tied to vaping-related illness.

 

Finally, MPF requests that the federal government and Anvisa be ordered to pay R$1 billion in collective moral damages, alleging regulatory omission has left the public unprotected and violated the constitutional right to health and sanitary safety.

 

Image source: Freepik

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Italian Court Ends Six-Year Cigarette Excise Dispute, Rejecting Damages Claim
Italian Court Ends Six-Year Cigarette Excise Dispute, Rejecting Damages Claim
Italy’s Lazio Regional Administrative Court has dismissed an appeal by Italian Tobacco Manufacturing and Manifattura Italiana Tabacco over the cigarette excise calculation mechanism, upholding the minimum tax burden rules and excluding compensation for smaller tobacco operators.
News
Jun.26 by 2Firsts Perspectives
FDA Grants MRTP Orders for 20 ZYN Nicotine Pouches
FDA Grants MRTP Orders for 20 ZYN Nicotine Pouches
The U.S. Food and Drug Administration (FDA) has issued modified risk granted orders to Swedish Match USA for 20 ZYN nicotine pouch products, allowing the already-authorized products to be marketed with a specific claim that using ZYN instead of cigarettes lowers the risk of mouth cancer, heart disease, lung cancer, stroke, emphysema and chronic bronchitis.
Jul.01
China’s Jiangsu Tobacco Monopoly Bureau and Drug Regulator Target Illegal Vape Sales Disguised as Medical Devices, Define Six Violations
China’s Jiangsu Tobacco Monopoly Bureau and Drug Regulator Target Illegal Vape Sales Disguised as Medical Devices, Define Six Violations
China’s Jiangsu Tobacco Monopoly Bureau and Jiangsu Provincial Medical Products Administration have issued a joint notice targeting illegal production and sales of vape products disguised as medical devices. The notice identifies six categories of violations, including obtaining medical licenses through false materials, misusing medical device credentials, expanding production beyond approved scopes, and using medical device-related online platforms to promote or sell vape products. The action is based on China’s tobacco and medical device regulations and aims to strengthen vape oversight and consumer protection.
Aug.04
IQOS Global Flagship Space to Open in Tokyo Ginza as PMI Expands Consumer Experience Strategy
IQOS Global Flagship Space to Open in Tokyo Ginza as PMI Expands Consumer Experience Strategy
Philip Morris Japan (PMJ) announced that it will open “IQOS Flagship Ginza” in Tokyo on September 4, 2026. The location will become the first global flagship space for PMI’s IQOS brand. PMJ said the venue will target adult smokers aged 20 and above and combine product experiences, community engagement and local cultural elements. The design will incorporate Japanese natural aesthetics and traditional craftsmanship. The launch reflects PMI’s broader strategy of strengthening consumer engagement through experiential retail and brand spaces. The existing IQOS Store Ginza is scheduled to close on August 30, 2026.
Jul.21
Vape Industry Group Loses Alabama Court Fight as State Tightens Rules on Imported Products
Vape Industry Group Loses Alabama Court Fight as State Tightens Rules on Imported Products
The Alabama Supreme Court affirmed a lower court’s refusal to issue a preliminary injunction blocking the state’s 2025 electronic nicotine delivery systems law, allowing rules requiring covered products to be U.S.-made or FDA-authorized to remain in effect.
Jul.10
ATF Cancels Webloc Contract, Raising Questions Over Commercial Location Data in Enforcement
ATF Cancels Webloc Contract, Raising Questions Over Commercial Location Data in Enforcement
The U.S. Bureau of Alcohol, Tobacco, Firearms and Explosives (ATF) has stopped using Webloc, a commercial phone-tracking tool, after lawmakers, a prosecutor and a judge raised legal and privacy concerns over warrantless use of ad-tech location data, a development that may affect data-use boundaries in U.S. enforcement against illicit tobacco, nicotine products and cross-border distribution networks.
Jun.29